222 related articles for article (PubMed ID: 7940952)
1. Synergistic interactions of cyclosporine, rapamycin, and brequinar on heart allograft survival in mice.
Stepkowski SM; Tu Y; Chou TC; Kahan BD
Transplant Proc; 1994 Oct; 26(5):3025-7. PubMed ID: 7940952
[No Abstract] [Full Text] [Related]
2. Triple combination of cyclosporine, brequinar, and rapamycin prolongs kidney allograft survival in the mongrel dog.
Ferraresso M; Knight R; Tu Y; Stepkowski SM; Kahan BD
Transplant Proc; 1994 Oct; 26(5):3028. PubMed ID: 7940953
[No Abstract] [Full Text] [Related]
3. The synergistic effects of cyclosporine, sirolimus, and brequinar on heart allograft survival in mice.
Tu Y; Stepkowski SM; Chou TC; Kahan BD
Transplantation; 1995 Jan; 59(2):177-83. PubMed ID: 7839437
[TBL] [Abstract][Full Text] [Related]
4. Brequinar sodium effectively and potently suppresses allograft rejection in a heterotopic mouse heart transplant model.
Murphy MP; Morris RE
Transplant Proc; 1993 Jun; 25(3 Suppl 2):75-6. PubMed ID: 7685955
[No Abstract] [Full Text] [Related]
5. Synergistic activity of the triple combination: cyclosporine, rapamycin, and brequinar.
Stepkowski SM; Kahan BD
Transplant Proc; 1993 Jun; 25(3 Suppl 2):29-31. PubMed ID: 8516939
[No Abstract] [Full Text] [Related]
6. Synergistic effect of 3M KCl-extracted donor antigens with cyclosporine or cyclosporine/rapamycin to prolong heart allograft survival in rats.
Hamashima T; Stepkowski SM; Smith S; Kahan BD
Transplant Proc; 1994 Oct; 26(5):3053-5. PubMed ID: 7940960
[No Abstract] [Full Text] [Related]
7. Rapamycin and cyclosporine synergistically prolong heart and kidney allograft survival.
Stepkowski SM; Kahan BD
Transplant Proc; 1991 Dec; 23(6):3262-4. PubMed ID: 1750091
[No Abstract] [Full Text] [Related]
8. Effect of cyclosporine alone or in combination with rapamycin and brequinar on survival of hamster heart xenograft in rats.
Wang M; Tu Y; Stepkowski SM; Kahan BD
Transplant Proc; 1993 Oct; 25(5):2876-7. PubMed ID: 8212271
[No Abstract] [Full Text] [Related]
9. A study of the contrasting effects of cyclosporine, FK 506, and rapamycin on the suppression of allograft rejection.
Morris RE; Wu J; Shorthouse R
Transplant Proc; 1990 Aug; 22(4):1638-41. PubMed ID: 1697111
[No Abstract] [Full Text] [Related]
10. Use of rapamycin for the suppression of alloimmune reactions in vivo: schedule dependence, tolerance induction, synergy with cyclosporine and FK 506, and effect on host-versus-graft and graft-versus-host reactions.
Morris RE; Meiser BM; Wu J; Shorthouse R; Wang J
Transplant Proc; 1991 Feb; 23(1 Pt 1):521-4. PubMed ID: 1703698
[No Abstract] [Full Text] [Related]
11. Combination therapy with Brequinar sodium and cyclosporine synergistically prolongs hamster-to-rat cardia xenograft survival.
Cosenza CA; Cramer DV; Tuso PJ; Chapman FA; Wang HK; Makowka L
J Heart Lung Transplant; 1994; 13(3):489-97. PubMed ID: 8061026
[TBL] [Abstract][Full Text] [Related]
12. Concentration-controlled immunosuppressive regimens using cyclosporine with sirolimus or brequinar in human renal transplantation.
Kahan BD
Transplant Proc; 1995 Feb; 27(1):33-6. PubMed ID: 7879019
[No Abstract] [Full Text] [Related]
13. Prolongation of skin allograft survival in mice treated with CTLA-4 Ig in combination with rapamycin or cyclosporine.
Hale DA; Gottschalk R; Wood ML; Maki T; Monaco AP
Transplant Proc; 1996 Dec; 28(6):3270-1. PubMed ID: 8962270
[No Abstract] [Full Text] [Related]
14. Comparison of rapamycin, RS 61443, cyclosporine, and low-dose heparin as treatment for transplant vasculopathy in a rat model of chronic allograft rejection.
Schmid C; Heemann U; Azuma H; Tilney NL
Transplant Proc; 1995 Feb; 27(1):438-9. PubMed ID: 7879053
[No Abstract] [Full Text] [Related]
15. A combination of anergic cells' adoptive transfer and rapamycin therapy prolongs cardiac allograft survival in mice.
Cai Y; Tang XD; Zhou PJ
Scand J Immunol; 2005 Mar; 61(3):266-73. PubMed ID: 15787744
[TBL] [Abstract][Full Text] [Related]
16. Synergistic interaction of FTY720 with cyclosporine or sirolimus to prolong heart allograft survival.
Stepkowski SM; Wang M; Qu X; Yu J; Okamoto M; Tejpal N; Kahan BD
Transplant Proc; 1998 Aug; 30(5):2214-6. PubMed ID: 9723445
[No Abstract] [Full Text] [Related]
17. Synergistic effect of rapamycin and cyclosporine in pancreaticoduodenal transplantation in the rat.
Chen H; Wu J; Luo H; Daloze P
Transplant Proc; 1992 Jun; 24(3):892-3. PubMed ID: 1604658
[No Abstract] [Full Text] [Related]
18. Evaluation of the use of brequinar sodium and cyclosporine combination therapy for preventing rat cardiac allograft rejection.
Cosenza CA; Cramer DV; Eiras-Hreha G; Cajulis E; Wang HK; Makowka L
Transplant Proc; 1993 Jun; 25(3 Suppl 2):57-8. PubMed ID: 8516945
[No Abstract] [Full Text] [Related]
19. Immunosuppressive effect of brequinar on rat cardiac allograft survival in combination with leflunomide or FK 506.
D'Silva M; Antoniou E; DeRoover A; Nishimura Y; Howie A; McMaster P
Transplant Proc; 1996 Apr; 28(2):950-1. PubMed ID: 8623476
[No Abstract] [Full Text] [Related]
20. Progressive change in tolerance mechanisms after withdrawing combination immunosuppression with cyclosporine and rapamycine or leflunomide.
Lin Y; Waer M
Transplant Proc; 1996 Dec; 28(6):3159. PubMed ID: 8962224
[No Abstract] [Full Text] [Related]
[Next] [New Search]
